Notably, inhibition of TGFβ1 can prevent CRC metastasis by unleashing a cytotoxic T cell response against cancer cells, implying that TGFβ1 signaling suppresses cancer recognition by the immune system (75, 76). Here, TGFB1 is linked to colorectal carcinoma.